Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

Strong trading action into final hour off of our ASH Conference presentation yesterday. Many ASH stocks pulled back considerably from a big morning move. Mast has held up nicely and it will be interesting to see how she closes out the day. Thought we might see 1.5 million shares by EOD but looks like we will fall short of that Mark.

As we have been range bound for sometime I've been looking at other bios with similar stories a few years back to get a feel for how they traded with and without news to get some speculative feel for what Mast might do over the next 24 months. The most interesting example I found was ACAD, which also had a failed-redesigned-late and ultimately successful late stage trial similar to our SCD EPIC study. If you are interested it is an easy bit of DD. Just read back through the news while following the daily historical price moves (Yahoo finance is an easy format). It is a nice example of where patience can payoff nicely and how individual trade timing is very difficult.

To reiterate my position with Mast, I am holding long due to continued solid data throughout our pipeline, a strong financial position, especially with our recent secondary offering and the increased percentage of quality institutional investment.

Have a great day everyone.
RR